Almac is pleased to announce the expansion of its drug product Pharmaceutical Development services with the creation of a new non-GMP formulation development facility and two new analytical laboratories at its UK headquarters in Craigavon. The new facilities double its current pharmaceutical development capacity.

The new non-GMP facility will primarily focus on lab-scale experiments, with batch sizes ranging from <1kg up to an expected maximum of 15 kg scale for most technologies.